Nanavati hospital doctor reviews treatment

INDORE: The chief radiotherapist of Nanavati Hospital, Mumbai, Dr Nagraj Huilgol reviewed treatment of patients using the indigenous Bhabhatron II teletherapy—an advance radiation therapy at the Indian Institute of Head and Neck Oncology, Indore Cancer Foundation on Friday.
Dr Huilgol reviewed the treatment of patients who are currently being treated by the institution using the indigenous Bhabhatron II teletherapy unit, which it has received as a grant-in-aid through the Department of Atomic Energy, Government of India.
Institution staff said that 42 patients are currently receiving radiotherapy every day and more than 1400 have been treated on Bhabhatron so far. Dr Nagraj, who is the Editor of Journal for Cancer Research and Therapeutics, suggested ways and means to reduce radiation’s side effects. Dr Suresh Verma, superintendent of the Institute and CM Dagaonkar, chairman, planning and development. Dr Amit Joshi, Dr Vikas Gupta and Dr Hamsa Nandini were present.